Literature DB >> 7627969

p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization.

S Kanjilal1, S S Strom, G L Clayman, R S Weber, A K el-Naggar, V Kapur, K K Cummings, L A Hill, M R Spitz, M L Kripke.   

Abstract

Multiple and distinct p53 mutations were detected by DNA sequence analysis in tumor and adjacent nonmalignant skin samples from eight patients with nonmelanoma skin cancer of the head and neck, providing unambiguous evidence for field cancerization. The mutations consisted of C-->T transitions at dipyrimidine sequences (30% of all single base substitutions), T-->C transitions (47%), and G-->T transversions (12%), suggesting that other carcinogens may act along with UV radiation in the development of nonmelanoma skin cancer. Patient interviews revealed that, in addition to substantial exposure to solar UV radiation, most had a history of smoking and were exposed to carcinogens from industrial or agricultural sources. These data show that extensive molecular epidemiological investigations are necessary to elucidate risk factors associated with the disease in localities where patients often report substantial exposure to environmental carcinogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627969

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation.

Authors:  M Murphy; M J E M F Mabruk; P Lenane; A Liew; P McCann; A Buckley; C O Flatharta; D Hevey; P Billet; W Robertson; S Javed; M Leader; E Kay; G M Murphy
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

Review 2.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

3.  DNA methylation: a marker for carcinogen exposure and cancer risk.

Authors:  Takeshi Nakajima; Shotaro Enomoto; Toshikazu Ushijima
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

4.  Comparison of "Lesion-by-Lesion" and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study.

Authors:  Inge Seubring; Joannes M M Groenewoud; Marie-Jeanne P Gerritsen
Journal:  Dermatology       Date:  2017-01-18       Impact factor: 5.366

5.  Role of PTCH and p53 genes in early-onset basal cell carcinoma.

Authors:  H Zhang; X L Ping; P K Lee; X L Wu; Y J Yao; M J Zhang; D N Silvers; D Ratner; R Malhotra; M Peacocke; H C Tsou
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 6.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

Review 7.  Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.

Authors:  Zheng Zhang; Pei-Chin Tsai; Tannaz Ramezanli; Bozena B Michniak-Kohn
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-02-05

8.  Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis.

Authors:  Yasuhiro Matsumura; Angus M Moodycliffe; Dat X Nghiem; Stephen E Ullrich; Honnavara N Ananthaswamy
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  UVR exposure sensitizes keratinocytes to DNA adduct formation.

Authors:  Sudhir Nair; Vikram D Kekatpure; Benjamin L Judson; Arleen B Rifkind; Richard D Granstein; Jay O Boyle; Kotha Subbaramaiah; Joseph B Guttenplan; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-29

10.  PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas.

Authors:  Jordan M Sand; Moammir H Aziz; Nancy E Dreckschmidt; Thomas C Havighurst; KyungMann Kim; Terry D Oberley; Ajit K Verma
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.